Global and extended coagulation monitoring during extracorporeal lung assist with heparin-coated systems in ARDS patients

International Journal of Artificial Organs

Volumn 20, Issue 1, 1997, Pages 29-36

  Gerlach, M ^a   Fohre B ^a   Keh, D ^a   Riess, H ^b   Falke, K J ^a   Gerlach, H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

acute respiratory distress syndrome; ARDS; clotting tests; coagulation; extracorporeal bypass systems; extracorporeal circulation

Indexed keywords

BIOLOGICAL ORGANS; POLYSACCHARIDES;

ACTIVATED PARTIAL THROMBOPLASTIN TIME; ACUTE RESPIRATORY DISTRESS SYNDROME; ARDS; BYPASS SYSTEMS; CLOTTING TEST; COAGULATION TIME; COATED SYSTEMS; EXTRACORPOREAL BYPASS SYSTEM; EXTRACORPOREAL CIRCULATION; HEPARINIZATION;

COAGULATION;

HEPARIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLEEDING; BLOOD CLOTTING; CLINICAL ARTICLE; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MALE;

EID: 0031053179     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702000107     Document Type: Article

References (38)

1. Anderson HL 3rd, Shapiro MB, Delius RE, Steimle CN, Chapman RA, Bartlett RH. Extracorporeal life support for respiratory failure after multiple trauma. J Trauma 1994; 37: 266-72.
2. Gattinoni L, Pesenti A, Bombino M, Pelosi P, Brazzi L. Role of extracorporeal circulation in adult respiratory distress syndrome management. New Horizons 1993; 1: 603-12.
3. 2 removal in severe acute respiratory failure. JAMA 1986; 256: 881-6.
4. Zapol WM, Snider MT, Hill JD, et al. Extracrporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective Studie. JAMA 1979; 242: 2193-6.
5. Hill JD, O'Brien TG, Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). N Engl J Med 1972; 286: 629-34.
6. Uziel L, Cugno M, Fabrizi I, Pesenti A, Gattinoni L, Agostoni A. Physiopathology and management of coagulation during long-term extracorporeal respiratory assistance, Int J Artif Organs 1990; 13: 280-7.
7. 2-removal with a heparin coated artificial lung. Intensive CareMed 1988; 14: 578-84.
8. Wendel HP, Heller W, Gallimore MJ, Hoffmeister HE. Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model. Blood Coagulation and Fibrinolyisis, 1994; 5: 673-8.
9. Svennevig JI, Geiran OR, Karlsen H, et al. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1993; 106: 466-72.
10. Kodama K, Pasche B, Olsson P, et al. AT III binding to surface immobilized heparin and its relation to F Xa inhibition. Thromb Haemostas 1987; 58: 1064-7.
11. Pasche B, Kodama K, Larm O, Olsson P, Swedenborg J. Thrombin inactivation on surfaces with covalently bonded heparin. Thrombos Res 1986; 44: 739-48.
12. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Dev Art Org 1983; 11: 161-73.
13. Mottaghy K, Oedekoven B, Pöppel K, et al. Heparin-coated versus non-coated surfaces for extracorporeal circulation, Int J Artif Organs 1991; 14: 721-8.
14. Kirschfink M, Kovacs B, Mottaghy K. Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces. Circ Shock 1993; 40: 221-6.
15. Shanley CJ, Hultquist KA, Rosenberg DM, McKenzie Jm, Shah NL, Bartlett RH. Prolonged extracorporeal circulation without heparin. Evaluation of the Medtronic Minimax oxygenator. ASAIO J 1992; 38: M311-6.
16. Koul B, Vesterqist O, Egberg N, Steen S. Twenty-four-hour heparin free veno-right-ventricular ECMO: an experimental study. Ann Thorac Surg 1992; 53: 1046-51.
17. Bindslev L, Gouda I, Inacio J, et al. Extracorporeal elimination of carbon dioxide using a surface-heparinized veno-venous bypass system. ASAIO Trans 1986; 32: 530-3.
18. Willms D, Dembitsky W. Prolonged extracorporeal support for ARDS using surface-heparinized equipment. Chest 1992; 102: 968-70.
19. Knoch M, Kollen B, Dietrich G, et al. Progress in veno-venous long-term bypass techniques for the treatment of ARDS. Controlled clinical trial with the heparin-coated bypass circuit, Int J Artif Organs 1992; 15: 103-8.
20. Rossaint R, Slama K, Lewandowski K, et al. Extracorporeal lung assist with heparin-coated systems, Int J Artif Organs 1992:15: 29-34.
21. Rossaint R, Slama K, Lewandowski K, et al. Major thoracic surgery during long-term extracorporeal lung assist for treatment of severe adult respiratory distress syndrome (ARDS). Eur J Cardiothorac Surg 1992; 6: 43-5.
22. 2 removal performed with surface-heparinized equipment in patients with ARDS. Acta Anaesthesiol Scand 1991; 95 (suppl): 125-30.
23. Bindslev L, Eklud J, Norlander O, et al. Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anes-thesiol 1987; 67: 117-20.
24. Plotz FB, van Oeveren W, Bartlett RH, et al. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993; 105: 823-32.
25. van der Kamp KWHJ, van Oeveren W. Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery, Int J Artif Organs 1993; 16: 836-42.
26. Bick RL. The clinical significance of fibrinogen degradation products. Semin Thromb Hemost 1983; 8: 302-30.
27. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008-16..
28. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326: 800-6.
29. Webb AR, Mythen MG, Jacobson D, Mackie IJ. Maintaining blood flow in the extracorporeal circuit: hemostasis and anticoagulation. Intensive Care Med 1995; 21: 84-93.
30. Rinder CS, Gaal D, Student LA, Smith BR. Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 107: 208-8.
31. Gravlee GP, Whitaker CL, Mark LJ, Rogers AT, Royster R, Harrison GA. Baseline activated coagulation time should be measured after surgical incision. Anesth Analg 1990; 71: 549-53.
32. Bookstein JJ, Arun K. Experimental investigation of hypercoagulant conditions associated with angiography. J Vasc Interv Radiol 1995; 6: 197-204.
33. Daugschies A, Altfeld E, Rommel M. Hemostatic alterations in pigs fed sublethal doses of Sarcocystis miescheriana Vet Parasital 1989; 34: 1-13.
34. Ding AW, Wu H, Kong LD, et al. Research on hemostatic mechanism of extracts from carbonized Schizonepeta tenuifolia Brig. Chung Kuo Chung Yao Tsa Chih 1993; 18: 598-600.
35. Olivieri O, Friso S, Manzato F, et al. Resistance to activated protein C in healthy women taking oral contraceptives. Br J Haematol 1995; 91: 465-70.
36. Fukutomi T, Nanasawa T, Yanamoto H, Adachi I, Watanabe T. The induction of a hypercoagulable state by medroxyprogesterone acetate in breast cancer patients; Jpn J Surg 1990: 20: 665-70.
37. Furui H, Taniguchi N, Yamauchi K, Sotobata I, Saito H, Inagaki H. Effects of treadmill exercise on platelet function, blood coagulability and fibrinolytic activity in patients with atrial fibrillation. Jpn Heart J 1987; 28: 177-84.
38. Braude S, Nolop K, Fleming J, Krausz T, Taylor K, Royston D. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass: association with lung neutrophil sequestration and tissue peroxidation. Am Rev Respir Dis 1986; 123: 867-71.